PACB vs PH · rev $38.4M vs P/E 28, rev $19.85B
Pacific Biosciences of California (PACB) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
PACB currently screens at market cap $387.1M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the PACB and PH stock pages for the full models.
Not investment advice.